Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Acceleron Pharma Inc.
  6. News
  7. Summary
    XLRN   US00434H1086

ACCELERON PHARMA INC.

(XLRN)
End-of-day quote Nasdaq  -  11-18
178.75 USD   -0.52%
2021GLOBAL MARKETS LIVE : Airbus, BP, Merck, Pfizer, Meta...
2021Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
DJ
2021ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from NASDAQ Biotechnology Index
CI
SummaryQuotesChartsNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Acceleron Pharma Inc.(NasdaqGM:XLRN) dropped from S&P TMI Index

11/22/2021 | 12:00am EDT
share with twitter
share with LinkedIn
share with facebook

Acceleron Pharma Inc.(NasdaqGM:XLRN) dropped from S&P TMI Index


© S&P Capital IQ 2021
All news about ACCELERON PHARMA INC.
2021GLOBAL MARKETS LIVE : Airbus, BP, Merck, Pfizer, Meta...
2021Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
DJ
2021ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from NASDAQ Biotechnology Index
CI
2021ACCELERON PHARMA : Completion of Acquisition or Disposition of Assets - Form 8-K
PU
2021ACCELERON PHARMA INC : Completion of Acquisition or Disposition of Assets, Notice of Delis..
AQ
2021Merck Completes Acceleron Pharma Acquisition
MT
2021Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
AQ
2021Merck Completes Cash Tender Offer to Purchase Acceleron Pharma at $180/Share
MT
2021ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from S&P Biotechnology Select Industry Inde..
CI
2021ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from S&P TMI Index
CI
More news
Analyst Recommendations on ACCELERON PHARMA INC.
More recommendations
Chart ACCELERON PHARMA INC.
Duration : Period :
Acceleron Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Rita A. Karachun President
Kevin F. McLaughlin Chief Financial Officer & Senior Vice President
Ravindra Kumar Chief Scientific Officer & Senior Vice President
Lisa Wyman Vice President-Operations
Aaron Rosenberg Treasurer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
ACCELERON PHARMA INC.0.00%10 932
GILEAD SCIENCES, INC.-14.10%78 232
REGENERON PHARMACEUTICALS, INC.2.22%69 552
VERTEX PHARMACEUTICALS12.35%63 100
WUXI APPTEC CO., LTD.-14.92%43 023
BIONTECH SE-38.39%38 601